在家庭护理的拉丁裔患者中进行皮下莱维他胺剂的使用
Laura Cuellar-Valencia1,2, Angelica Claros-Hulbert1,2, Adriana Ortegon3,4
1Faculty of Medicine, Universidad de La Sabana, Bogotá DC, Colombia.
The American journal of hospice & palliative care
|October 31, 2023
概括
皮下使用的 levetiracetam 已在接受家庭护理的拉丁裔患者中证明了安全性和有效性. 这项研究表明,当口服不可能时,它是一种可行的非标签选择.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
背景情况:
- 列维他拉塞坦具有有利的药理学,可用于皮下注射.
- 目前关于皮下使用 levetiracetam 的证据仅限于观察性研究.
- 它的皮下使用被认为是标签外的.
研究的目的:
- 评估皮下使用 levetiracetam 的安全性和有效性.
- 专注于接受家庭护理的拉丁裔患者.
- 在现实环境中评估耐受性和有效性.
主要方法:
- 追溯观察案例系列研究.
- 涉及15名拉丁裔成年患者,患有限制生命的疾病.
- 使用标准化标准收集关于安全性,有效性和不良事件的数据.
主要成果:
- 皮下使用 levetiracetam 平均持续了 21 天.
- 最常见的启动原因是失去口服途径.
- 只有1名患者需要调整剂量;2名患者有发作;没有报道任何不良反应.
结论:
- 在这种患者群体中,皮下 levetiracetam 似乎是有效和安全的.
- 这一案例系列扩大了其在家庭护理环境中使用的证据.
- 根据初步数据,需要进一步进行可靠的试验.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
318
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Routes of Drug Administration: Parenteral
2.0K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.0K
Drug Delivery: Parenteral Route
570
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
570
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
74
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
74
Insulin: Dosing Regimen and Adverse Effects
184
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
184


